Ramis M. Shabaev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ramis M. Shabaev has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Dmitry Alekseevich Blagovestnov
Russian Medical Academy of Continuing Professional Education
9 shared publications - Pavel M. Starokon
Kirov Military Medical Academy
8 shared publications - Irina Vladimirovna Kolyadina
Russian Medical Academy of Continuous Professional Education
6 shared publications - Evgeniy Aleksandrovich Toneev
Regional Clinical Oncology Dispensary; Ulyanovsk State University
4 shared publications - Roman Fatykhovich Shagdaleev
Ulyanovsk State University
3 shared publications - A. D. Teriagova
Ulyanovsk State University
2 shared publications
Latest Publications
- 24 June 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 3,p. 77-86
How to improve wound healing in extensive breast surgeries (a literature review)
The purpose of the study is to evaluate the possibilities of modern methods for correcting the wound healing process in extensive breast surgeries. Materials and methods. A review of medical literature published using the MEDLINE, Scopus, Clinicaltrials.gov, Google Scholar, and Web of Science information and analytical systems was performed. The review was conducted in accordance with the checklist of preferred reporting elements for systematic reviews and meta-analyses. A total of 350 original publications were selected, and 30 original scientific articles on the research topic were included in the analysis. The search depth was limited to the last 10 years. The study explored the potential of modern methods to improve wound healing during extensive breast surgeries. Results. The article presents a systematization of the most common complications that occur after surgical interventions, as well as the prerequisites for their occurrence. An analysis of modern specialized literature has confirmed the specifics of wound healing after extensive surgical interventions on the mammary gland. The outcome of healing and the recovery period have an impact on a woman's quality of life, physical health after an invasive procedure, and the patient's psychological state, which is influenced by their satisfaction with the treatment outcome and their aesthetic appearance. Therefore, it is crucial to analyze the risk factors and potential complications that may arise after extensive surgical interventions on the mammary gland. Conclusion. This knowledge will help the surgeon not only to make more accurate diagnoses and choose the most appropriate surgical intervention, but also to effectively prevent and treat complications and manage the patient postoperatively.
- 24 June 2026
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 3,p. 77-86
How to improve wound healing in extensive breast surgeries (a literature review)
The purpose of the study is to evaluate the possibilities of modern methods for correcting the wound healing process in extensive breast surgeries. Materials and methods. A review of medical literature published using the MEDLINE, Scopus, Clinicaltrials.gov, Google Scholar, and Web of Science information and analytical systems was performed. The review was conducted in accordance with the checklist of preferred reporting elements for systematic reviews and meta-analyses. A total of 350 original publications were selected, and 30 original scientific articles on the research topic were included in the analysis. The search depth was limited to the last 10 years. The study explored the potential of modern methods to improve wound healing during extensive breast surgeries. Results. The article presents a systematization of the most common complications that occur after surgical interventions, as well as the prerequisites for their occurrence. An analysis of modern specialized literature has confirmed the specifics of wound healing after extensive surgical interventions on the mammary gland. The outcome of healing and the recovery period have an impact on a woman's quality of life, physical health after an invasive procedure, and the patient's psychological state, which is influenced by their satisfaction with the treatment outcome and their aesthetic appearance. Therefore, it is crucial to analyze the risk factors and potential complications that may arise after extensive surgical interventions on the mammary gland. Conclusion. This knowledge will help the surgeon not only to make more accurate diagnoses and choose the most appropriate surgical intervention, but also to effectively prevent and treat complications and manage the patient postoperatively.
- Open Access
- 10 May 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 15 (1) , 33-43
Randomized Clinical Trial of the Effectiveness of Thoracotomy Wound Management for the Prevention of Infectious Complications and Additional Anesthesia
Relevance Thoracotomy is a widely used method of access to the chest, however, its use is associated with a high risk of surgical site infections. According to the World Health Organization, infectious complications are the most common problem in surgical practice. They can significantly worsen the patients’ condition after surgery, increase the length of their hospital stay and create significant financial difficulties for the healthcare system. The proposed method of thoracotomy wound management can significantly reduce the incidence of unwanted postoperative infections, which, in turn, will reduce the burden on the healthcare system. The aim of the study To evaluate the effectiveness of the proposed method of thoracotomy wound management after anatomical lung resections, in order to prevent infection after surgery and additional anesthesia by comparative analysis with the control group. Material and methods The study was conducted on the basis of the Department of Thoracic Oncology Surgery of the Regional Clinical Oncological Dispensary, Ulyanovsk, Russia. The analysis included 63 patients at high and medium risk of developing surgical site infections (SSIs), who were divided into two groups of 32 and 31 people. Group 1 (32 patients) was the control group, group 2 (31 patients) were patients who underwent the developed method of complex thoracotomy wound management. All the patients underwent elective thoracotomy for anatomical lung resection (lobectomy or segmentectomy) in the period from 06/15/2023 to 11/18/2024. The characteristics of the studied patients were evaluated according to a single developed protocol. Results The incidence of SSIs in the control group was 28.1% (9/32), while in the group where preventive management of the postoperative wound was performed, this indicator was 6.5% (2/31), p=0.043. When performing a one-factor statistical analysis of the postoperative parameters of the studied groups of patients, statistically significant indicators were determined: the pain visual analog scale on day 1 (p=0.006), neutrophil-lymphocyte ratio on day 1 (p=0.003), platelet-lymphocyte ratio on day 1 (p=0.039); cortisol level on day 1 day (p=0.004) and day 5 (p=0.017); forced expiratory volume in 1 second and vital capacity for 1 day after surgery (p=0.038) and (p=0.027), respectively, forced vital capacity for 1 day after surgery (p=0.033). Conclusions The application of the developed technique for the management of postoperative thoracotomy wounds reduces the development of infectious complications in patients with moderate and high risk of surgical site infections, and also provides adequate anesthesia.
- 10 May 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 15 (1) , 33-43
Open AccessRandomized Clinical Trial of the Effectiveness of Thoracotomy Wound Management for the Prevention of Infectious Complications and Additional Anesthesia
Relevance Thoracotomy is a widely used method of access to the chest, however, its use is associated with a high risk of surgical site infections. According to the World Health Organization, infectious complications are the most common problem in surgical practice. They can significantly worsen the patients’ condition after surgery, increase the length of their hospital stay and create significant financial difficulties for the healthcare system. The proposed method of thoracotomy wound management can significantly reduce the incidence of unwanted postoperative infections, which, in turn, will reduce the burden on the healthcare system. The aim of the study To evaluate the effectiveness of the proposed method of thoracotomy wound management after anatomical lung resections, in order to prevent infection after surgery and additional anesthesia by comparative analysis with the control group. Material and methods The study was conducted on the basis of the Department of Thoracic Oncology Surgery of the Regional Clinical Oncological Dispensary, Ulyanovsk, Russia. The analysis included 63 patients at high and medium risk of developing surgical site infections (SSIs), who were divided into two groups of 32 and 31 people. Group 1 (32 patients) was the control group, group 2 (31 patients) were patients who underwent the developed method of complex thoracotomy wound management. All the patients underwent elective thoracotomy for anatomical lung resection (lobectomy or segmentectomy) in the period from 06/15/2023 to 11/18/2024. The characteristics of the studied patients were evaluated according to a single developed protocol. Results The incidence of SSIs in the control group was 28.1% (9/32), while in the group where preventive management of the postoperative wound was performed, this indicator was 6.5% (2/31), p=0.043. When performing a one-factor statistical analysis of the postoperative parameters of the studied groups of patients, statistically significant indicators were determined: the pain visual analog scale on day 1 (p=0.006), neutrophil-lymphocyte ratio on day 1 (p=0.003), platelet-lymphocyte ratio on day 1 (p=0.039); cortisol level on day 1 day (p=0.004) and day 5 (p=0.017); forced expiratory volume in 1 second and vital capacity for 1 day after surgery (p=0.038) and (p=0.027), respectively, forced vital capacity for 1 day after surgery (p=0.033). Conclusions The application of the developed technique for the management of postoperative thoracotomy wounds reduces the development of infectious complications in patients with moderate and high risk of surgical site infections, and also provides adequate anesthesia.
- 30 January 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (4)
Development and Validation of a Predictive Model for the Diagnosis of Acute Appendicitis in Children
Objective To develop a predictive model for diagnosing acute appendicitis in pediatric patients. Material and methods The study was conducted at the Surgical Department of Ulyanovsk Regional Children’s Clinical Hospital from September 1, 2023, to June 1, 2024. The analysis included patients admitted with suspected acute appendicitis. A total of 400 patients were included in the study, of which 300 were diagnosed with acute appendicitis, and 100 had functional bowel disorders. Patient characteristics were assessed using a standardized protocol. Results Univariate statistical analysis showed that the differential diagnosis of these conditions is most frequently required in children aged 6–12 years. Logistic regression analysis indicated that nausea (OR 11.586; 95% CI 3.347–40.125), white blood cell count (OR 1.52; 95% CI 1.343–1.721), lymphocyte count (OR 0.59; 95% CI 0.371–0.939), age (OR 1.207; 95% CI 1.079–1.350), appendix diameter of >6 mm (OR 32.691; 95% CI 12.846–83.179), and vomiting (OR 0.121; 95% CI 0.03–0.487) were independent risk factors for acute appendicitis in children during differential diagnosis. The identified variables were included in a nomogram using logistic regression analysis. The validation results showed that the area under the ROC curve was 0.967±0.008, with a 95% CI of 0.951–0.983. The developed model was statistically significant (pConclusion A nomogram and an interactive prognostic calculator were developed for predicting the presence of acute appendicitis in children, which can be used for differential diagnosis with functional bowel disorders.
- 30 January 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (4)
Development and Validation of a Predictive Model for the Diagnosis of Acute Appendicitis in Children
Objective To develop a predictive model for diagnosing acute appendicitis in pediatric patients. Material and methods The study was conducted at the Surgical Department of Ulyanovsk Regional Children’s Clinical Hospital from September 1, 2023, to June 1, 2024. The analysis included patients admitted with suspected acute appendicitis. A total of 400 patients were included in the study, of which 300 were diagnosed with acute appendicitis, and 100 had functional bowel disorders. Patient characteristics were assessed using a standardized protocol. Results Univariate statistical analysis showed that the differential diagnosis of these conditions is most frequently required in children aged 6–12 years. Logistic regression analysis indicated that nausea (OR 11.586; 95% CI 3.347–40.125), white blood cell count (OR 1.52; 95% CI 1.343–1.721), lymphocyte count (OR 0.59; 95% CI 0.371–0.939), age (OR 1.207; 95% CI 1.079–1.350), appendix diameter of >6 mm (OR 32.691; 95% CI 12.846–83.179), and vomiting (OR 0.121; 95% CI 0.03–0.487) were independent risk factors for acute appendicitis in children during differential diagnosis. The identified variables were included in a nomogram using logistic regression analysis. The validation results showed that the area under the ROC curve was 0.967±0.008, with a 95% CI of 0.951–0.983. The developed model was statistically significant (pConclusion A nomogram and an interactive prognostic calculator were developed for predicting the presence of acute appendicitis in children, which can be used for differential diagnosis with functional bowel disorders.
- 30 January 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (4)
Prevention of Surgical Site Infections After Elective Laparotomies
Aim of study. To evaluate the effectiveness of the proposed method for preventing surgical site infections (SSI) and reducing postoperative pain. Material and methods. A randomized clinical study was conducted, including 58 patients from the medium and high-risk groups for developing SSI, who underwent midline laparotomy from January 1, 2024, to May 15, 2024, at two institutions: Ulyanovsk Regional Clinical Hospital and Ulyanovsk Regional Oncological Dispensary. Results. Univariate statistical analysis revealed that patient clinical data—gender, age, type of surgical intervention, and comorbidities — were not statistically significant. Analysis of laboratory parameters — including the leukocyte intoxication index according to V.K. Ostrovsky, neutrophil-lymphocyte ratio (NLR), plateletlymphocyte ratio (PLR), C-reactive protein (CRP) level, and cortisol level — were significantly lower on the 5th day in the experimental group, which was statistically significant. Additionally, the incidence of surgical site infections was significantly lower in the experimental group (3/29, 10.3%) compared to the control group (7/29, 24.1%), p=0.03. No differences were found between the groups in the structure of infectious complications at the surgical site. During statistical analysis, it was determined that in the study group, the Visual Analogue Scale (VAS) score on the third postoperative day was significantly lower than in the control group (p=0.048). Conclusion. The use of the proposed method in clinical practice during midline laparotomy may be an effective and safe technique for preventing surgical site infections and reducing postoperative pain.
- 30 January 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (4)
Prevention of Surgical Site Infections After Elective Laparotomies
Aim of study. To evaluate the effectiveness of the proposed method for preventing surgical site infections (SSI) and reducing postoperative pain. Material and methods. A randomized clinical study was conducted, including 58 patients from the medium and high-risk groups for developing SSI, who underwent midline laparotomy from January 1, 2024, to May 15, 2024, at two institutions: Ulyanovsk Regional Clinical Hospital and Ulyanovsk Regional Oncological Dispensary. Results. Univariate statistical analysis revealed that patient clinical data—gender, age, type of surgical intervention, and comorbidities — were not statistically significant. Analysis of laboratory parameters — including the leukocyte intoxication index according to V.K. Ostrovsky, neutrophil-lymphocyte ratio (NLR), plateletlymphocyte ratio (PLR), C-reactive protein (CRP) level, and cortisol level — were significantly lower on the 5th day in the experimental group, which was statistically significant. Additionally, the incidence of surgical site infections was significantly lower in the experimental group (3/29, 10.3%) compared to the control group (7/29, 24.1%), p=0.03. No differences were found between the groups in the structure of infectious complications at the surgical site. During statistical analysis, it was determined that in the study group, the Visual Analogue Scale (VAS) score on the third postoperative day was significantly lower than in the control group (p=0.048). Conclusion. The use of the proposed method in clinical practice during midline laparotomy may be an effective and safe technique for preventing surgical site infections and reducing postoperative pain.
- Open Access
- 6 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2996
Xymedon Activates the Immune Response in Breast Cancer Xenografts
Background/Objectives: Breast cancer remains a major cause of cancer-related mortality among women worldwide, highlighting the need for new therapeutic strategies. Pyrimidine derivatives have shown promise in oncology due to their ability to modulate immune responses and influence tumor growth pathways. Methods: Cytotoxicity of Xymedon was evaluated using MTT and colony formation assays on cancer MCF-7, NCI-H322M, HCT-15 cells, and primary human foreskin fibroblasts. In vivo efficacy was assessed in an orthotopic MCF-7 xenograft model in female Balb/c nude mice. Xymedon was administered orally at 410 mg/kg daily alone or in combination with intraperitoneal doxorubicin (1 mg/kg weekly). Hematological, histological, and immunohistochemical analyses were performed. Results: In vitro, Xymedon (up to 3 mM) showed no cytotoxicity against cancer cell lines or human skin fibroblasts. In vivo, Xymedon significantly increased tumor necrosis (44.1% vs. 28.5%, p < 0.01) and enhanced intratumoral infiltration of CD3+, CD8+, and CD20+ lymphocytes, with peritumoral counts increasing 2.2–5.3-fold. It mitigated Doxorubicin-induced myelosuppression by improving red blood cell counts, hemoglobin, and hematocrit levels, while platelet recovery remained limited. Combination therapy with Xymedon did not affect tumor volume or weight, but resulted in a non-significant trend toward improved survival (80% vs. 30%, p ≈ 0.11; Hazard Ratio [HR] = 0.268, 95% CI: 0.07082 to 1.012) without affecting fibrous capsule formation. Conclusions: These results suggest that Xymedon is a non-cytotoxic immunomodulator with potential as an adjuvant to enhance antitumor immunity and reduce hematologic toxicity associated with chemotherapy. Further studies are needed to elucidate the molecular pathways and confirm clinical efficacy.
- 6 December 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2996
Open AccessXymedon Activates the Immune Response in Breast Cancer Xenografts
Background/Objectives: Breast cancer remains a major cause of cancer-related mortality among women worldwide, highlighting the need for new therapeutic strategies. Pyrimidine derivatives have shown promise in oncology due to their ability to modulate immune responses and influence tumor growth pathways. Methods: Cytotoxicity of Xymedon was evaluated using MTT and colony formation assays on cancer MCF-7, NCI-H322M, HCT-15 cells, and primary human foreskin fibroblasts. In vivo efficacy was assessed in an orthotopic MCF-7 xenograft model in female Balb/c nude mice. Xymedon was administered orally at 410 mg/kg daily alone or in combination with intraperitoneal doxorubicin (1 mg/kg weekly). Hematological, histological, and immunohistochemical analyses were performed. Results: In vitro, Xymedon (up to 3 mM) showed no cytotoxicity against cancer cell lines or human skin fibroblasts. In vivo, Xymedon significantly increased tumor necrosis (44.1% vs. 28.5%, p < 0.01) and enhanced intratumoral infiltration of CD3+, CD8+, and CD20+ lymphocytes, with peritumoral counts increasing 2.2–5.3-fold. It mitigated Doxorubicin-induced myelosuppression by improving red blood cell counts, hemoglobin, and hematocrit levels, while platelet recovery remained limited. Combination therapy with Xymedon did not affect tumor volume or weight, but resulted in a non-significant trend toward improved survival (80% vs. 30%, p ≈ 0.11; Hazard Ratio [HR] = 0.268, 95% CI: 0.07082 to 1.012) without affecting fibrous capsule formation. Conclusions: These results suggest that Xymedon is a non-cytotoxic immunomodulator with potential as an adjuvant to enhance antitumor immunity and reduce hematologic toxicity associated with chemotherapy. Further studies are needed to elucidate the molecular pathways and confirm clinical efficacy.
- Open Access
- 4 August 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (3) , 103-113
Results of chemoradiotherapy with CROSS regimen for middle third esophageal cancer
Background. Esophageal cancer (EC) is one of the most aggressive gastrointestinal malignancies with a poor prognosis. The standard treatment for thoracic EC involves chemoradiotherapy (CRT). For localized tumors, a multimodal approach, including neoadjuvant chemoradiotherapy followed by surgery, is considered optimal. This approach can improve long-term treatment outcomes and provide better local control. The CROSS regimen is a commonly used chemoradiotherapy regimen for EC in Europe and Russia.Objective: to evaluate the effectiveness of chemoradiotherapy with the CROSS regimen administered both preoperatively and alone, as well as to assess long-term overall and recurrence-free survival rates.Material and Methods. This retrospective study included patients with stage I–III thoracic esophageal cancer treated at the Ulyanovsk Regional Clinical Oncology Center from January 1, 2019, to December 31, 2023. A total of 94 patients began chemoradiotherapy in the CROSS regimen. The final analysis included 80 (85.1 %) patients who completed the entire treatment program. Data collection was performed according to a unified protocol.Results. The rate of complete pathological response (TRG 1) was 10/26 (38.5 %). The 1-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 83.3 % and 71.7 %, respectively. The 3-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 58.3 % and 50.9 %, respectively. The 1-year and 3-year recurrence-free survival rates were higher in patients who received CRT followed by surgery compared to those who received CRT alone (76.9 % versus 63.5 % and 53.9 % versus 44.2 %).Conclusion. Chemoradiotherapy with the CROSS regimen was shown to achieve a complete response in more than a third of EC patients. Survival rates were higher in patients undergoing a three-modality approach.
- 4 August 2025
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 24 (3) , 103-113
Open AccessResults of chemoradiotherapy with CROSS regimen for middle third esophageal cancer
Background. Esophageal cancer (EC) is one of the most aggressive gastrointestinal malignancies with a poor prognosis. The standard treatment for thoracic EC involves chemoradiotherapy (CRT). For localized tumors, a multimodal approach, including neoadjuvant chemoradiotherapy followed by surgery, is considered optimal. This approach can improve long-term treatment outcomes and provide better local control. The CROSS regimen is a commonly used chemoradiotherapy regimen for EC in Europe and Russia.Objective: to evaluate the effectiveness of chemoradiotherapy with the CROSS regimen administered both preoperatively and alone, as well as to assess long-term overall and recurrence-free survival rates.Material and Methods. This retrospective study included patients with stage I–III thoracic esophageal cancer treated at the Ulyanovsk Regional Clinical Oncology Center from January 1, 2019, to December 31, 2023. A total of 94 patients began chemoradiotherapy in the CROSS regimen. The final analysis included 80 (85.1 %) patients who completed the entire treatment program. Data collection was performed according to a unified protocol.Results. The rate of complete pathological response (TRG 1) was 10/26 (38.5 %). The 1-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 83.3 % and 71.7 %, respectively. The 3-year overall survival rates in patients undergoing surgery and in patients not undergoing surgery were 58.3 % and 50.9 %, respectively. The 1-year and 3-year recurrence-free survival rates were higher in patients who received CRT followed by surgery compared to those who received CRT alone (76.9 % versus 63.5 % and 53.9 % versus 44.2 %).Conclusion. Chemoradiotherapy with the CROSS regimen was shown to achieve a complete response in more than a third of EC patients. Survival rates were higher in patients undergoing a three-modality approach.
- Open Access
- 8 May 2025
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 21 (1) , 29-43
Modern possibilities of surgical treatment of benign breast tumors with ptosis: comparative analysis and long-term outcomes
Aim. To evaluate the effectiveness of a new method for removing multiple benign breast tumors through a single access with subsequent correction of ptosis using a hemispherical glandular flap in comparison with bilateral sectoral resection of the mammary glands.Materials and methods. A prospective observational study was conducted involving 154 patients with benign breast tumors who were treated from 2022 to 2024. The patients were divided into two groups depending on the type of surgery performed: group I included 78 women with removal of multiple breast tumors through a single surgical access with subsequent correction of ptosis using a hemispherical glandular flap, group II included 76 patients with bilateral sectoral resection of the mammary glands. A comparative analysis of these types of surgical treatment of benign breast tumors was performed, and the quality of life of the patients before surgery and one year after surgical treatment were assessed.Results. When comparing the early postoperative period, no significant differences were found between the new method of removing multiple breast tumors through a single surgical access with subsequent correction of ptosis with a hemispherical glandular flap and bilateral resection of the mammary glands in terms of the number of hospital days, pain syndrome and sensitivity of the nipple-areolar complex. Carrying out surgical treatment with one-stage correction of ptosis allowed all patients to achieve a good long-term aesthetic result, avoid asymmetry, gross deformation of the mammary glands, while in group 2, 71 % of patients had aesthetic defects after surgery, p0.001. Evaluation of the mental component of quality of life one year after surgery showed a significant advantage of performing surgical treatment in group 1 compared to that in group 2, p 0.001, which is most likely due to the removal of multiple breast tumors with simultaneous elimination of mammary ptosis, which had a positive effect on the psychoemotional state and quality of life of women.Conclusion. Our results prove the high efficiency and advantage of a new surgical method for removing multiple benign breast tumors through a single approach with subsequent correction of ptosis with a hemispherical glandular flap in terms of immediate surgical and long-term aesthetic results and improving the quality of life of patients.
- 8 May 2025
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 21 (1) , 29-43
Open AccessModern possibilities of surgical treatment of benign breast tumors with ptosis: comparative analysis and long-term outcomes
Aim. To evaluate the effectiveness of a new method for removing multiple benign breast tumors through a single access with subsequent correction of ptosis using a hemispherical glandular flap in comparison with bilateral sectoral resection of the mammary glands.Materials and methods. A prospective observational study was conducted involving 154 patients with benign breast tumors who were treated from 2022 to 2024. The patients were divided into two groups depending on the type of surgery performed: group I included 78 women with removal of multiple breast tumors through a single surgical access with subsequent correction of ptosis using a hemispherical glandular flap, group II included 76 patients with bilateral sectoral resection of the mammary glands. A comparative analysis of these types of surgical treatment of benign breast tumors was performed, and the quality of life of the patients before surgery and one year after surgical treatment were assessed.Results. When comparing the early postoperative period, no significant differences were found between the new method of removing multiple breast tumors through a single surgical access with subsequent correction of ptosis with a hemispherical glandular flap and bilateral resection of the mammary glands in terms of the number of hospital days, pain syndrome and sensitivity of the nipple-areolar complex. Carrying out surgical treatment with one-stage correction of ptosis allowed all patients to achieve a good long-term aesthetic result, avoid asymmetry, gross deformation of the mammary glands, while in group 2, 71 % of patients had aesthetic defects after surgery, p0.001. Evaluation of the mental component of quality of life one year after surgery showed a significant advantage of performing surgical treatment in group 1 compared to that in group 2, p 0.001, which is most likely due to the removal of multiple breast tumors with simultaneous elimination of mammary ptosis, which had a positive effect on the psychoemotional state and quality of life of women.Conclusion. Our results prove the high efficiency and advantage of a new surgical method for removing multiple benign breast tumors through a single approach with subsequent correction of ptosis with a hemispherical glandular flap in terms of immediate surgical and long-term aesthetic results and improving the quality of life of patients.
- Open Access
- 3 December 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (4) , 21-32
Minimally invasive percutaneous surgical methods (laser ablation and sclerotherapy) in the treatment of benign breast disease with a prevailing cystic component: short-term and long-term outcomes
Background. Benign breast disease (BBD) is the most common multidisciplinary problem in women globally. Surgery enables complete removal of the pathological tissue and its morphological assessment. However, breast sectoral resection causes excessive injury, increases the risk of postoperative complications, and might result in aesthetic defects. The capacity of minimally invasive surgeries, such as laser ablation and sclerotherapy, for treating breast cysts should be thoroughly analyzed since these methods might provide a highly effective alternative to conventional surgical strategies.Aim. To evaluate treatment efficacy and quality of life in BBD patients with a prevailing cystic component who underwent minimally invasive percutaneous surgeries and sectoral breast resection.Materials and methods. This retrospective study included 471 BBD patients with a prevailing cystic component. Women were divided into three groups depending on the surgery type: 1) sectoral resection (n = 155 (32.9 %)); 2) ultrasoundguided percutaneous laser ablation (n = 152 (32.3 %)); 3) ultrasound-guided percutaneous sclerotherapy with 1 % solution of sodium tetradecyl sulfate (n = 164 (34.8 %)). In each group, we evaluated short-term surgery outcomes, surgery duration, length of hospital stay, incidence and severity of early postoperative complications, pain intensity in the early postoperative period, and aesthetic results and quality of life 24 months postoperatively.Results. We observed a significant advantage of minimally invasive percutaneous surgeries over sectoral resection as they were faster and required shorter in-hospital stay (p 0.01). Better aesthetic results and stable results (no recurrent cysts) 24 months postoperatively were observed in patients after laser ablation and sclerotherapy rather than after sectoral resection (p 0.01). Minimally invasive percutaneous surgeries caused less pain than sectoral resection and, therefore, these patients didn’t need nonsteroidal anti-inflammatory drugs (p 0.01). BBD with a prevailing cystic component resulted in a reduced quality of life in all patients before treatment. All types of surgery (both minimally invasive and conventional) had a positive effect on the quality of life in the long-term perspective. The improvement of the quality of life was more pronounced in patients after laser ablation and sclerotherapy than in those after sectoral resection (p 0.01).Conclusion. Minimally invasive percutaneous surgical methods (laser ablation and sclerotherapy) were highly effective in BBD patients with a prevailing cystic component. They reduced injury, ensured good aesthetic results, and increased patients’ quality of life.
- 3 December 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (4) , 21-32
Open AccessMinimally invasive percutaneous surgical methods (laser ablation and sclerotherapy) in the treatment of benign breast disease with a prevailing cystic component: short-term and long-term outcomes
Background. Benign breast disease (BBD) is the most common multidisciplinary problem in women globally. Surgery enables complete removal of the pathological tissue and its morphological assessment. However, breast sectoral resection causes excessive injury, increases the risk of postoperative complications, and might result in aesthetic defects. The capacity of minimally invasive surgeries, such as laser ablation and sclerotherapy, for treating breast cysts should be thoroughly analyzed since these methods might provide a highly effective alternative to conventional surgical strategies.Aim. To evaluate treatment efficacy and quality of life in BBD patients with a prevailing cystic component who underwent minimally invasive percutaneous surgeries and sectoral breast resection.Materials and methods. This retrospective study included 471 BBD patients with a prevailing cystic component. Women were divided into three groups depending on the surgery type: 1) sectoral resection (n = 155 (32.9 %)); 2) ultrasoundguided percutaneous laser ablation (n = 152 (32.3 %)); 3) ultrasound-guided percutaneous sclerotherapy with 1 % solution of sodium tetradecyl sulfate (n = 164 (34.8 %)). In each group, we evaluated short-term surgery outcomes, surgery duration, length of hospital stay, incidence and severity of early postoperative complications, pain intensity in the early postoperative period, and aesthetic results and quality of life 24 months postoperatively.Results. We observed a significant advantage of minimally invasive percutaneous surgeries over sectoral resection as they were faster and required shorter in-hospital stay (p 0.01). Better aesthetic results and stable results (no recurrent cysts) 24 months postoperatively were observed in patients after laser ablation and sclerotherapy rather than after sectoral resection (p 0.01). Minimally invasive percutaneous surgeries caused less pain than sectoral resection and, therefore, these patients didn’t need nonsteroidal anti-inflammatory drugs (p 0.01). BBD with a prevailing cystic component resulted in a reduced quality of life in all patients before treatment. All types of surgery (both minimally invasive and conventional) had a positive effect on the quality of life in the long-term perspective. The improvement of the quality of life was more pronounced in patients after laser ablation and sclerotherapy than in those after sectoral resection (p 0.01).Conclusion. Minimally invasive percutaneous surgical methods (laser ablation and sclerotherapy) were highly effective in BBD patients with a prevailing cystic component. They reduced injury, ensured good aesthetic results, and increased patients’ quality of life.
- Open Access
- 15 May 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (1) , 31-38
Risk factors for breast cancer in patients with benign breast diseases: a 10-year observational study
Aim. To assess risk factors for breast cancer in a large population of women with benign breast dysplasia (BBD) followed up for a long time.Materials and methods. This retrospective study included 504 women with BBD followed up for 10 years. Study participants were divided into two groups: 1) BBD patients who did not develop breast cancer within 10 years (n = 261); 2) BBD patients who developed breast cancer within 10 years (n = 243). We conducted comprehensive retrospective analysis of demographic, clinical, and laboratory characteristics, as well as treatment details for BBD. Patient age varied between 39 and 49 years. The ten-year follow-up interval was chosen to perform adequate comparison of the groups. The differences were considered significant at p 0.05.Results. The main difference between the two groups was related to conservative treatment for BBD and its duration. Almost all (93.4 %) patients in the group without breast cancer received some conservative treatment for BBD for 78.0 ± 1.7 months, whereas among those who developed breast cancer, only 37.4 % received conservative therapy for 15.0 ± 0.8 months (p 0.001). Other significant risk factors for breast cancer in group 2 included obesity, gynecological pathology, long-term stress, and no surgical treatment for benign breast changes (p 0.001). The analysis of laboratory parameters demonstrated significantly higher levels of prolactin in patients who developed breast cancer (31 % versus 13 %; p 0.001).Conclusion. Potential risk factors for breast cancer in BBD patients include overweight, benign gynecological diseases, elevated prolactin, and long-term stress. Timely diagnosis and treatment of BBD and elimination of the abovementioned factors can significantly reduce the probability of breast cancer.
- 15 May 2024
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 20 (1) , 31-38
Open AccessRisk factors for breast cancer in patients with benign breast diseases: a 10-year observational study
Aim. To assess risk factors for breast cancer in a large population of women with benign breast dysplasia (BBD) followed up for a long time.Materials and methods. This retrospective study included 504 women with BBD followed up for 10 years. Study participants were divided into two groups: 1) BBD patients who did not develop breast cancer within 10 years (n = 261); 2) BBD patients who developed breast cancer within 10 years (n = 243). We conducted comprehensive retrospective analysis of demographic, clinical, and laboratory characteristics, as well as treatment details for BBD. Patient age varied between 39 and 49 years. The ten-year follow-up interval was chosen to perform adequate comparison of the groups. The differences were considered significant at p 0.05.Results. The main difference between the two groups was related to conservative treatment for BBD and its duration. Almost all (93.4 %) patients in the group without breast cancer received some conservative treatment for BBD for 78.0 ± 1.7 months, whereas among those who developed breast cancer, only 37.4 % received conservative therapy for 15.0 ± 0.8 months (p 0.001). Other significant risk factors for breast cancer in group 2 included obesity, gynecological pathology, long-term stress, and no surgical treatment for benign breast changes (p 0.001). The analysis of laboratory parameters demonstrated significantly higher levels of prolactin in patients who developed breast cancer (31 % versus 13 %; p 0.001).Conclusion. Potential risk factors for breast cancer in BBD patients include overweight, benign gynecological diseases, elevated prolactin, and long-term stress. Timely diagnosis and treatment of BBD and elimination of the abovementioned factors can significantly reduce the probability of breast cancer.
- Open Access
- 21 February 2024
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (4) , 440-446
The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
Background. Partial mastectomy is the method of choice for the surgical treatment of benign neoplasms (BN) of the breast. The drawback of this technique is the occurrence of residual cavities with the accumulation of serous and hemorrhagic exudate, promoting inflammation. Hydroxyethyl dimethyldihydropyrimidine (Ximedon) in the postoperative treatment improves the healing and overall treatment outcomes. Materials and methods. The study included 101 patients. All of them had a partial mastectomy for the BN. The study patients received different pharmacotherapy in the postoperative period. They were divided into two groups depending on the use of hydroxyethyl dimethyldihydropyrimidine. Group 1 included 52 (51.5%) patients who received hydroxyethyl dimethyldihydropyrimidine 2 hours before surgery and 0.5 g on days 1 to 7 in the postoperative period. Group 2 included 49 (48.5%) patients who had not received hydroxyethyl dimethyldihydropyrimidine. Results. Analysis of treatment outcomes showed that in group 1 patients receiving hydroxyethyl dimethyldihydropyrimidine, the overall treatment results were better. Therefore, hydroxyethyldimethyldihydropyrimidine improved overall treatment outcomes and increased patients' quality of life in the postoperative period. Conclusion. The use of hydroxyethyldimethyldihydropyrimidine in the postoperative period, which has a protective effect at the cellular level due to membrane-stabilizing, antioxidant, adaptogenic, and antibacterial properties, is promising and improves wound healing, thus improving the overall results of surgical treatment of breast BNs.
- 21 February 2024
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (4) , 440-446
Open AccessThe use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast
Background. Partial mastectomy is the method of choice for the surgical treatment of benign neoplasms (BN) of the breast. The drawback of this technique is the occurrence of residual cavities with the accumulation of serous and hemorrhagic exudate, promoting inflammation. Hydroxyethyl dimethyldihydropyrimidine (Ximedon) in the postoperative treatment improves the healing and overall treatment outcomes. Materials and methods. The study included 101 patients. All of them had a partial mastectomy for the BN. The study patients received different pharmacotherapy in the postoperative period. They were divided into two groups depending on the use of hydroxyethyl dimethyldihydropyrimidine. Group 1 included 52 (51.5%) patients who received hydroxyethyl dimethyldihydropyrimidine 2 hours before surgery and 0.5 g on days 1 to 7 in the postoperative period. Group 2 included 49 (48.5%) patients who had not received hydroxyethyl dimethyldihydropyrimidine. Results. Analysis of treatment outcomes showed that in group 1 patients receiving hydroxyethyl dimethyldihydropyrimidine, the overall treatment results were better. Therefore, hydroxyethyldimethyldihydropyrimidine improved overall treatment outcomes and increased patients' quality of life in the postoperative period. Conclusion. The use of hydroxyethyldimethyldihydropyrimidine in the postoperative period, which has a protective effect at the cellular level due to membrane-stabilizing, antioxidant, adaptogenic, and antibacterial properties, is promising and improves wound healing, thus improving the overall results of surgical treatment of breast BNs.